Orphazyme's total assets for Q2 2022 were $93.59M, a decrease of -45.97% from the previous quarter. GB:0CUM total liabilities were $15.38M for the fiscal quarter, a -92.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.